FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/09/057361 [Registered on: 11/09/2023] Trial Registered Prospectively
Last Modified On: 09/09/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Preventive 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A study to compare the effectiveness of KETOFOL AND KETOFOL-DEXMEDETOMIDINE drugs in patients undergoing modified electroconvulsive therapy. 
Scientific Title of Study   A randomised clinical trial to compare the effectiveness of KETOFOL and KETOFOL-DEXMEDETOMIDINE groups in patients undergoing modified electroconvulsive therapy. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Charishma Buddha 
Designation  Junior Resident in Anaesthesiology 
Affiliation  Shri B M Patil Medical College ,Vijayapura 
Address  Department of Anaesthesiology,Shri B M Patil Medical College,Bangaramma Sajjan Campus,Vijayapura Bijapur

Bijapur
KARNATAKA
586103
India 
Phone  8919259121  
Fax    
Email  charishma.goutham@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  D G Talikoti  
Designation  Professor 
Affiliation  Shri B M Patil Medical College, Vijayapura 
Address  Department of Anaesthesiology,Shri B M Patil Medical College,Bangaramma Sajjan Campus,Vijayapura Bijapur

Bijapur
KARNATAKA
586103
India 
Phone  9844260391  
Fax    
Email  dtalikoti@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Charishma Buddha 
Designation  Junior Resident in Anaesthesiology 
Affiliation  Shri B M Patil Medical College ,Vijayapura 
Address  Department of Anaesthesiology,Shri B M Patil Medical College,Bangaramma Sajjan Campus,Vijayapura Bijapur

Bijapur
KARNATAKA
586103
India 
Phone  8919259121  
Fax    
Email  charishma.goutham@gmail.com  
 
Source of Monetary or Material Support  
Shri B M Patil Medical College,Bangaramma Sajjan Campus,BLDE University,Vijayapura,Karnataka,Pin 586103 
 
Primary Sponsor  
Name  Shri B M Patil Medical College 
Address  Bangaramma Sajjan Campus,BLDE University,Vijayapura,Karnataka,Pin 586103  
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Charishma Buddha   Shri B M Patil Medical College  Department of Anaesthesiology, Bangaramma Sajjan Campus,BLDE University,Vijayapura,
Bijapur
KARNATAKA 
8919259121

charishma.goutham@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Shri B M Patil Medical College  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F40-F48||Anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders, (2) ICD-10 Condition: F01-F99||Mental, Behavioral and Neurodevelopmental disorders, (3) ICD-10 Condition: F20-F29||Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  ketofol  K.F. group 10 ml of 0.9% saline was infused intravenously over a period of 10 minutes and 10 minutes before the procedure.  
Intervention  ketofol-dexmedetomidine  In KFD -group 0.5 μg/kg dexmedetomidine (diluted to 10 ml with 0.9% saline) was infused intravenously over a period of 10 minutes and 10 minutes prior to the procedure.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients with ASA Grade I & II 
 
ExclusionCriteria 
Details  Cardiovascular disease,
Cerebrovascular disorder,
Intracranial hypertension,
Respiratory tract disease,
Glaucoma,
Presence of a pacemaker,
History of seizures,
ASA III –V physical status,
History of allergy to the study drugs,
Pregnancy
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
To assess seizure duration
To evaluate an acceptable decrease in heart rate & blood pressure (systolic, diastolic)
 
5 & 10 & 30 minutes after the end of the seizure 
 
Secondary Outcome  
Outcome  TimePoints 
To assess agitation
 
24 hours  
To assess depression , mania, psychosis  24 hours 
To assess early post-M.E.C.T. complications.
 
24 hours 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   19/09/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="30" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   A Randomised clinical trial to compare the effectiveness of ketofol and ketofol-dexmedetomidine group in patients undergoing modified electroconvulsive therapy. Patients will be divided randomly into two equal groups, consisting of thirty patients each, the ketofol (K.F. group and ketofol-dexmedetomidine( KFD) group).This study will be carried out in the Department of Anaesthesiology, B.L.D.E.U.’s Shri. B.M. Patil Medical College, Hospital and Research Centre, Vijayapura . The primary outcome is to assess seizure duration and to evaluate an acceptable decrease in heart rate and blood pressure (systolic, diastolic) .The secondary outcome is to assess agitation ,to assess depression , mania, psychosis and to assess early post-M.E.C.T. complications. 
Close